Financials data is unavailable for this security.
View more
Year on year Alterity Therapeutics Ltd had net income fall 38.51% from a loss of 13.81m to a larger loss of 19.12m despite a 1,532.73% increase in revenues from 16.44k to 268.42k.
Gross margin | -- |
---|---|
Net profit margin | -7,124.45% |
Operating margin | -7,204.58% |
Return on assets | -82.18% |
---|---|
Return on equity | -104.47% |
Return on investment | -103.97% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Alterity Therapeutics Ltd fell by 3.13m. Cash Flow from Financing totalled 9.22m or 3,433.53% of revenues. In addition the company used 12.61m for operations while cash used for investing totalled 5.72k.
Cash flow per share | -0.0052 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0026 |
---|---|
Tangible book value per share | 0.0026 |
More ▼
Balance sheet in AUDView more
Current ratio | 3.54 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0115 |
---|---|
Total debt/total capital | 0.0114 |
More ▼